ELK1 |
ELK1: ETS domain-containing protein Elk-1 |
HES1 |
HES1, HL, HRY: Transcription factor HES-1 |
4.032 |
Evidence |
|
OXTR |
OXTR: Oxytocin receptor |
AVPR1B |
AVPR1B, AVPR3, VPR3: Vasopressin V1b receptor |
4.032 |
Evidence |
|
ACVR1B |
ACVR1B, ACVRLK4: Activin receptor type-1B precursor |
NUP214 |
IPI00643352 |
4.03 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
CFTR |
CFTR: Cystic fibrosis transmembrane conductance regulator ATP-binding cassette s |
4.03 |
Evidence |
|
C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
4.03 |
Evidence |
|
CENTA1 |
CENTA1: Centaurin-alpha 1 |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
4.03 |
Evidence |
|
BCL2 |
BCL2: Apoptosis regulator Bcl-2 |
RPS6KA2 |
RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 |
4.03 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
GRIN2A |
GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor |
4.03 |
Evidence |
|
EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
ESR1 |
ESR1, ESR, NR3A1: Estrogen receptor |
4.03 |
Evidence |
|
BCL2 |
BCL2: Apoptosis regulator Bcl-2 |
MKNK1 |
MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 |
4.03 |
Evidence |
|
NOS2A |
NOS2A, NOS2: Nitric oxide synthase, inducible |
GRK1 |
GRK1, RHOK: Rhodopsin kinase precursor |
4.03 |
Evidence |
|
KRT18 |
KRT18: Uncharacterized protein KRT18 |
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
4.03 |
Evidence |
|
PRKAR1A |
PRKAR1A, PKR1, PRKAR1, TSE1: cAMP-dependent protein kinase type I-alpha regulato |
TLE3 |
TLE3, KIAA1547: Transducin-like enhancer protein 3 |
4.03 |
Evidence |
|
PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
CFTR |
CFTR: Cystic fibrosis transmembrane conductance regulator ATP-binding cassette s |
4.03 |
Evidence |
|
ACVR1B |
ACVR1B, ACVRLK4: Activin receptor type-1B precursor |
IRF3 |
IRF3: Interferon regulatory factor 3 |
4.03 |
Evidence |
|
KRT8 |
KRT8, CYK8: Keratin, type II cytoskeletal 8 |
RPS6KA2 |
RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 |
4.03 |
Evidence |
|
PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
DUSP3 |
DUSP3, VHR: Dual specificity protein phosphatase 3 |
4.03 |
Evidence |
|
LAT |
LAT: Linker for activation of T-cells family member 1 |
SOS1 |
SOS1: Son of sevenless homolog 1 |
4.03 |
Evidence |
|
GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
4.03 |
Evidence |
|
GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
4.03 |
Evidence |
|
PDLIM5 |
PDLIM5, ENH: PDZ and LIM domain protein 5 |
TRPV1 |
TRPV1: Vanilloid receptor variant TRPV1b |
4.025 |
Evidence |
|
ICAM2 |
ICAM2: Intercellular adhesion molecule 2 precursor |
BAIAP2 |
BAIAP2: Brain-specific angiogenesis inhibitor 1-associated protein 2 |
4.025 |
Evidence |
|
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
SIGLEC12 |
SIGLEC12, SIGLECL1, UNQ9215/PRO34042, SLG: Sialic acid-binding Ig-like lectin 12 |
4.025 |
Evidence |
|
F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
RGS18 |
RGS18, RGS13: Regulator of G-protein signaling 18 |
4.025 |
Evidence |
|
TBXA2R |
TBXA2R: Thromboxane A2 receptor |
RGS4 |
RGS4: Regulator of G-protein signaling 4 |
4.025 |
Evidence |
|